circ‑0000212 promotes cell proliferation of colorectal cancer by sponging miR‑491 and modulating FOXP4 expression

Wu,Hongyu; Wu,Hongyu; Wu,Hongyu; Tao,Yangbao; Tao,Yangbao; Tao,Yangbao; Zhang,Weiyuan; Zhang,Weiyuan; Zhang,Weiyuan; Wang,Guiyu; Wang,Guiyu; Wang,Guiyu; Zhang,Qian; Zhang,Qian; Zhang,Qian

doi:10.3892/mmr.2021.11939

circ‑0000212 promotes cell proliferation of colorectal cancer by sponging miR‑491 and modulating FOXP4 expression

Authors:
- Hongyu Wu
- Yangbao Tao
- Weiyuan Zhang
- Guiyu Wang
- Qian Zhang
View Affiliations

Affiliations: Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China
Published online on: February 24, 2021 https://doi.org/10.3892/mmr.2021.11939
Article Number: 300
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer (CRC) is a lethal and common malignancy worldwide. Non‑coding (nc)RNAs have been shown to modulate tumor progression in several types of cancer. The present study aimed to investigate the role of hsa_circ_0000212 in CRC, as a sponge of microRNA (miR)‑491. The expression levels of miR‑491 and forkhead box P4 (FOXP4) were analyzed using data from The Cancer Genome Atlas. The association between miR‑491 and FOXP4 and the clinicopathological characteristics were also analyzed. A novel circular (circ)RNA, hsa_circ_0000212, was found to sponge miR‑491 based on bioinformatics analysis. The potential binding site between miR‑491 and FOXP4 or circ‑0000212 was validated using luciferase and RNA immunoprecipitation assays. The expression levels and distribution of circ‑0000212 was also determined. Cell Counting Kit‑8 and colony formation assays were performed to determine the role of miR‑491 or circ‑0000212 on the proliferation of the CRC cells. Decreased miR‑491 or increased FOXP4 expression levels were associated with the pathological stage in patients with CRC. In addition, miR‑491 inhibited cell proliferation by targeting FOXP4. circ‑0000212 was increased in CRC tissues and was predominantly localized in the cytoplasm. Furthermore, circ‑0000212 augmented viability of the CRC cells by sponging miR‑491 and modulating FOXP4. In conclusion, circ‑0000212 may serve as a novel tumor‑promoter and drug target in CRC.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
2	Adams BD, Parsons C, Walker L, Zhang WC and Slack FJ: Targeting noncoding RNAs in disease. J Clin Invest. 127:761–771. 2017. View Article : Google Scholar : PubMed/NCBI
3	Lekka E and Hall J: Noncoding RNAs in disease. FEBS Lett. 592:2884–2900. 2018. View Article : Google Scholar : PubMed/NCBI
4	Lorenzi L, Avila Cobos F, Decock A, Everaert C, Helsmoortel H, Lefever S, Verboom K, Volders PJ, Speleman F, Vandesompele J and Mestdagh P: Long noncoding RNA expression profiling in cancer: Challenges and opportunities. Genes Chromosomes Cancer. 58:191–199. 2019. View Article : Google Scholar : PubMed/NCBI
5	Garzon R, Marcucci G and Croce CM: Targeting microRNAs in cancer: Rationale, strategies and challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
6	Corté H, Manceau G, Blons H and Laurent-Puig P: MicroRNA and colorectal cancer. Dig Liver Dis. 44:195–200. 2012. View Article : Google Scholar : PubMed/NCBI
7	Yang L, Belaguli N and Berger DH: MicroRNA and colorectal cancer. World J Surg. 33:638–646. 2009. View Article : Google Scholar : PubMed/NCBI
8	Acunzo M, Romano G, Wernicke D and Croce CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9. 2015. View Article : Google Scholar : PubMed/NCBI
9	Wilusz JE and Sharp PA: Molecular biology. A circuitous route to noncoding RNA. Science. 340:440–441. 2013. View Article : Google Scholar : PubMed/NCBI
10	Qu S, Zhong Y, Shang R, Zhang X, Song W, Kjems J and Li H: The emerging landscape of circular RNA in life processes. RNA Biol. 14:992–999. 2017. View Article : Google Scholar : PubMed/NCBI
11	Zhou DN, Ye CS and Deng YF: CircRNAs: Potency of protein translation and feasibility of novel biomarkers and therapeutic targets for head and neck cancers. Am J Transl Res. 12:1535–1552. 2020.PubMed/NCBI
12	Liu J, Zhang X, Yan M and Li H: Emerging role of circular RNAs in cancer. Front Oncol. 10:6632020. View Article : Google Scholar : PubMed/NCBI
13	Zhong Z, Huang M, Lv M, He Y, Duan C, Zhang L and Chen J: Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Cancer Lett. 403:305–317. 2017. View Article : Google Scholar : PubMed/NCBI
14	Barrett SP and Salzman J: Circular RNAs: Analysis, expression and potential functions. Development. 143:1838–1847. 2016. View Article : Google Scholar : PubMed/NCBI
15	Zhang L, Dong X, Yan B, Yu W and Shan L: CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1. Cell Death Dis. 11:5422020. View Article : Google Scholar : PubMed/NCBI
16	Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 7:112152016. View Article : Google Scholar : PubMed/NCBI
17	Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM, Castiglioni I, et al: TCGAbiolinks: An R/bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44:e712016. View Article : Google Scholar : PubMed/NCBI
18	Zellweger T, Miyake H, Cooper S, Chi K, Conklin BS, Monia BP and Gleave ME: Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2′-O-(2-methoxy)ethyl chemistry. J Pharmacol Exp Ther. 298:934–940. 2001.PubMed/NCBI
19	Zhao ZJ and Shen J: Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol. 14:514–521. 2017. View Article : Google Scholar : PubMed/NCBI
20	Gwak J, Jeong H, Lee K, Shin JY, Sim T, Na J, Kim J and Ju BG: SFMBT2-mediated infiltration of preadipocytes and TAMs in prostate cancer. Cancers (Basel). 12:27182020. View Article : Google Scholar
21	Gwak J, Shin JY, Lee K, Hong SK, Oh S, Goh SH, Kim WS and Ju BG: SFMBT2 (Scm-like with four mbt domains 2) negatively regulates cell migration and invasion in prostate cancer cells. Oncotarget. 7:48250–48264. 2016. View Article : Google Scholar : PubMed/NCBI
22	Ma T and Zhang J: Upregulation of FOXP4 in breast cancer promotes migration and invasion through facilitating EMT. Cancer Manag Res. 11:2783–2793. 2019. View Article : Google Scholar : PubMed/NCBI
23	Zhang G and Zhang G: Upregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT. Oncol Lett. 17:3944–3951. 2019.PubMed/NCBI
24	Tan GZ, Li M, Tan X, Shi ML and Mou K: miR-491 suppresses migration and invasion via directly targeting TPX2 in breast cancer. Eur Rev Med Pharmacol Sci. 23:9996–10004. 2019.PubMed/NCBI
25	Meng Y, Shang FR and Zhu YL: miR-491 functions as a tumor suppressor through Wnt3a/β-catenin signaling in the development of glioma. Eur Rev Med Pharmacol Sci. 23:10899–10907. 2019.PubMed/NCBI
26	Liu Z, Lü Y, Jiang Q, Yang Y, Dang C and Sun R: miR-491 inhibits BGC-823 cell migration via targeting HMGA2. Int J Biol Markers. 34:364–372. 2019. View Article : Google Scholar : PubMed/NCBI
27	Yu T, Wang LN, Li W, Zuo QF, Li MM, Zou QM and Xiao B: Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4. Cancer Sci. 109:1393–1403. 2018. View Article : Google Scholar : PubMed/NCBI
28	Xu Y, Hou R, Lu Q, Zhang Y, Chen L, Zheng Y and Hu B: miR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer. Am J Cancer Res. 7:2545–2553. 2017.PubMed/NCBI
29	Cheng Q, Xu X, Jiang H, Xu L and Li Q: Knockdown of long non-coding RNA XIST suppresses nasopharyngeal carcinoma progression by activating miR-491-5p. J Cell Biochem. 119:3936–3944. 2018. View Article : Google Scholar : PubMed/NCBI
30	Hanisch C, Sharbati J, Kutz-Lohroff B, Huber O, Einspanier R and Sharbati S: TFF3-dependent resistance of human colorectal adenocarcinoma cells HT-29/B6 to apoptosis is mediated by miR-491-5p regulation of lncRNA PRINS. Cell Death Discov. 3:161062017. View Article : Google Scholar : PubMed/NCBI
31	Chen LL: The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 21:475–490. 2020. View Article : Google Scholar : PubMed/NCBI
32	Zhou ZB, Huang GX, Fu Q, Han B, Lu JJ, Chen AM and Zhu L: circRNA.33186 contributes to the pathogenesis of osteoarthritis by sponging miR-127-5p. Mol Ther. 27:531–541. 2019. View Article : Google Scholar : PubMed/NCBI
33	Liu Z, Yu Y, Huang Z, Kong Y, Hu X, Xiao W, Quan J and Fan X: CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression. Cell Death Dis. 10:9002019. View Article : Google Scholar : PubMed/NCBI
34	Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P and Wu M: CircRNA: Functions and properties of a novel potential biomarker for cancer. Mol Cancer. 16:942017. View Article : Google Scholar : PubMed/NCBI
35	Hsiao KY, Lin YC, Gupta SK, Chang N, Yen L, Sun HS and Tsai SJ: Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Cancer Res. 77:2339–2350. 2017. View Article : Google Scholar : PubMed/NCBI
36	Wang K, Sun Y, Tao W, Fei X and Chang C: Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1miR-195-5p/29a-3p/29c-3p/CDC42 signals. Cancer Lett. 394:1–12. 2017. View Article : Google Scholar : PubMed/NCBI
37	Guo X, Dai X, Liu J, Cheng A, Qin C and Wang Z: Circular RNA circREPS2 Acts as a sponge of miR-558 to suppress gastric cancer progression by regulating RUNX3/β-catenin signaling. Mol Ther Nucleic Acids. 21:577–591. 2020. View Article : Google Scholar : PubMed/NCBI
38	Zhao WX, Tang YL, Wang WH and Bao MW: Up-regulation of circ_0000353 impedes the proliferation and metastasis of non-small cell lung cancer cells via adsorbing miR-411-5p and increasing forkhead box O1. Cancer Biomark. 29:25–37. 2020. View Article : Google Scholar : PubMed/NCBI
39	Lee K, Na W, Maeng JH, Wu H and Ju BG: Regulation of DU145 prostate cancer cell growth by Scm-like with four mbt domains 2. J Biosci. 38:105–112. 2013. View Article : Google Scholar : PubMed/NCBI
40	Hussain S, Sun M, Guo Y, Mushtaq N, Zhao Y, Yuan Y, Hussain N, Osoro E, Suleiman A, Sadiq M, et al: SFMBT2 positively regulates SOX9 and chondrocyte proliferation. Int J Mol Med. 42:3503–3512. 2018.PubMed/NCBI
41	Litke JL and Jaffrey SR: Highly efficient expression of circular RNA aptamers in cells using autocatalytic transcripts. Nat Biotechnol. 37:667–675. 2019. View Article : Google Scholar : PubMed/NCBI
42	Jost I, Shalamova LA, Gerresheim GK, Niepmann M, Bindereif A and Rossbach O: Functional sequestration of microRNA-122 from hepatitis C virus by circular RNA sponges. RNA Biol. 15:1032–1039. 2018.PubMed/NCBI
43	Liu CX, Li X, Nan F, Jiang S, Gao X, Guo SK, Xue W, Cui Y, Dong K, Ding H, et al: Structure and degradation of circular RNAs regulate PKR activation in innate immunity. Cell. 177:865–880.e21. 2019. View Article : Google Scholar : PubMed/NCBI
44	Chen YG, Kim MV, Chen X, Batista PJ, Aoyama S, Wilusz JE, Iwasaki A and Chang HY: Sensing self and foreign circular RNAs by intron identity. Mol Cell. 67:228–238.e5. 2017. View Article : Google Scholar : PubMed/NCBI
45	Bahn JH, Zhang Q, Li F, Chan TM, Lin X, Kim Y, Wong DT and Xiao X: The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem. 61:221–230. 2015. View Article : Google Scholar : PubMed/NCBI